Niklas Loman
Lund University(SE)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Ovarian cancer diagnosis and treatment, CRISPR and Genetic Engineering
Most-Cited Works
- → Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial(2010)1,629 cited
- → A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population(2010)341 cited
- → Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer(2011)193 cited
- → Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women(2016)70 cited
- → VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer(2022)39 cited
- → Whole‐body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study(2023)4 cited
- → 52P RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer(2022)3 cited
- → Is Breast-conserving Therapy Really a Good Option for BRCA1/2 Mutation Carriers?(2015)3 cited
- → Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.(2024)1 cited
- → Abstract P2-08-11: How reliable are biomarkers assessed on a core needle biopsy? A study of paired core needle biopsies and surgical specimens in early breast cancer(2022)